Roles of O‐linked oligosaccharides in immune responses

Many functional glycoproteins are expressed on the lymphocyte cell surface. Some of them carry O‐linked oligosaccharides (O‐glycans), which are conjugated through serine or threonine residues. During various biological processes, including T‐cell activation, a tetrasaccharide on the T‐cell surface is dramatically converted to a branched hexasaccharide, called core2 O‐glycan. The same structural change in O‐glycans is also found on the lymphocytes from patients with immunodeficiency conditions such as Wiskott‐Aldrich syndrome and AIDS. Several studies revealing the roles of core2 O‐glycans in immune responses show that this is a biologically significant change. In particular, core2 O‐glycans expressed on the cell surface reduce cell–cell interactions, thereby regulating immune responses. Furthermore, core2 O‐glycan is a key backbone structure in forming selectin ligands. Thus, O‐linked oligosaccharides, in particular those containing core2 branches, play vital roles in immune responses and may play dual roles in certain situations. This review will summarize the results obtained from various studies investigating the roles of O‐glycans in immunological processes. BioEssays 23:46–53, 2001. © 2001 John Wiley & Sons, Inc.

[1]  H. Clausen,et al.  Tumor-associated carbohydrate antigens. , 2007, Journal of oral pathology.

[2]  S. Tsuboi,et al.  Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1* , 2000, The Journal of Biological Chemistry.

[3]  J. Altman,et al.  Differentiating between Memory and Effector Cd8 T Cells by Altered Expression of Cell Surface O-Glycans , 2000, The Journal of experimental medicine.

[4]  J. Marth,et al.  The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. , 2000, Immunity.

[5]  S. Tsuboi,et al.  Expression of human Wiskott–Aldrich syndrome protein in patients’ cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins , 2000, Gene Therapy.

[6]  M. Fukuda,et al.  C-Type Lectins and Sialyl Lewis X Oligosaccharides , 1999, The Journal of cell biology.

[7]  S. Tsuboi,et al.  A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34. , 1999, Immunity.

[8]  V. Giordanengo,et al.  Inverse proportions of activated and CD4 circulating lymphocytes in AIDS patients. , 1999, AIDS.

[9]  S. Hemmerich,et al.  Sulfotransferases of Two Specificities Function in the Reconstitution of High Endothelial Cell Ligands for L-selectin , 1999, The Journal of cell biology.

[10]  M. Hollingsworth,et al.  Control of O-Glycan Branch Formation , 1999, The Journal of Biological Chemistry.

[11]  A. V. van Kessel,et al.  Control of O-Glycan Branch Formation , 1999, The Journal of Biological Chemistry.

[12]  T. Homma,et al.  Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells. , 1999, International immunology.

[13]  M. Fukuda,et al.  Molecular Cloning and Expression of a Novel β-1,6-N-Acetylglucosaminyltransferase That Forms Core 2, Core 4, and I Branches* , 1999, The Journal of Biological Chemistry.

[14]  S. Tsuboi,et al.  Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. , 1998, Immunity.

[15]  S. Tsuboi,et al.  Overexpression of Branched O-Linked Oligosaccharides on T Cell Surface Glycoproteins Impairs Humoral Immune Responses in Transgenic Mice* , 1998, The Journal of Biological Chemistry.

[16]  M. Fukuda,et al.  Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. , 1997, Cancer research.

[17]  S. Tsuboi,et al.  Branched O‐linked oligosaccharides ectopically expressed in transgenic mice reduce primary T‐cell immune responses , 1997, The EMBO journal.

[18]  S. Inoue,et al.  Identification of sulfated oligosialic acid units in the O-linked glycan of the sea urchin egg receptor for sperm. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Nadler,et al.  Characterization of a CD43/Leukosialin-mediated Pathway for Inducing Apoptosis in Human T-Lymphoblastoid Cells* , 1996, The Journal of Biological Chemistry.

[20]  L. Ellies,et al.  The CD43 130-kD peripheral T-cell activation antigen is downregulated in thymic positive selection. , 1996, Blood.

[21]  M. Fukuda Possible roles of tumor-associated carbohydrate antigens. , 1996, Cancer research.

[22]  U. Francke,et al.  Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization , 1996, Cell.

[23]  Richard D. Cummings,et al.  Post-translational Modifications of Recombinant P-selectin Glycoprotein Ligand-1 Required for Binding to P- and E-selectin (*) , 1996, The Journal of Biological Chemistry.

[24]  L. Baum,et al.  Apoptosis of T cells mediated by galectin-1 , 1995, Nature.

[25]  D. Gray,et al.  CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.

[26]  N. Manjunath,et al.  Negative regulation of T-cell adhesion and activation by CD43 , 1995, Nature.

[27]  T. B. Miller,et al.  Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. , 1995, The Journal of clinical investigation.

[28]  R. Hoffman,et al.  Apoptosis of human hematopoietic progenitor cells induced by crosslinking of surface CD43, the major sialoglycoprotein of leukocytes. , 1995, Blood.

[29]  S. Hemmerich,et al.  Structure of the O-Glycans in GlyCAM-1, an Endothelial-derived Ligand for L-selectin , 1995, The Journal of Biological Chemistry.

[30]  M. Fukuda,et al.  Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells , 1995, The Journal of experimental medicine.

[31]  J. Peyron,et al.  Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line , 1994, The Journal of experimental medicine.

[32]  U. Francke,et al.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.

[33]  R. Flavell,et al.  Mice deficient for the CD40 ligand. , 1994, Immunity.

[34]  N. Yoshida,et al.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. , 1994, Immunity.

[35]  I. Weissman Developmental switches in the immune system , 1994, Cell.

[36]  C. Terhorst,et al.  T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. , 1993, Journal of immunology.

[37]  M. Fukuda,et al.  Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans. , 1992, The Journal of biological chemistry.

[38]  M. Fukuda,et al.  Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Staunton,et al.  CD43 interferes with T-lymphocyte adhesion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Weinberg,et al.  Altered O-glycan synthesis in lymphocytes from patients with Wiskott- Aldrich syndrome , 1991, The Journal of experimental medicine.

[41]  J. Dennis,et al.  Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. , 1991, The Journal of biological chemistry.

[42]  D. Shotton,et al.  The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. , 1991, The EMBO journal.

[43]  M. Fukuda,et al.  T-lymphocytic leukemia expresses complex, branched O-linked oligosaccharides on a major sialoglycoprotein, leukosialin. , 1991, Blood.

[44]  I. Brockhausen,et al.  Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. , 1991, Cancer research.

[45]  J. Dennis,et al.  Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. , 1991, The Journal of biological chemistry.

[46]  D. Staunton,et al.  Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes , 1990, The Journal of experimental medicine.

[47]  J. Dennis,et al.  Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. , 1989, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[48]  M. Fukuda,et al.  Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. , 1988, The Journal of biological chemistry.

[49]  M. Fukuda,et al.  Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes. , 1986, The Journal of biological chemistry.

[50]  P. Wassarman,et al.  O-linked oligosaccharides of mouse egg ZP3 account for its sperm receptor activity , 1985, Cell.

[51]  T. Feizi Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens , 1985, Nature.

[52]  H. Ochs,et al.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. , 1980, Blood.

[53]  L. Andersson,et al.  Activated human T lymphocytes display new surface glycoproteins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Aldrich Ra,et al.  Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. , 1954 .

[55]  James,et al.  Increased UDP-GlcNAc:Gal@1-3GalNAc-R (GlcNAc to GalNAc) ,8-1,6-N-Acetylglucosaminyltransferase Activity in Metastatic Murine Tumor Cell Lines , 2001 .

[56]  下平 和久 Carcinoma-associated expression of core 2 β-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer : role of O-glycans in tumor progression , 1999 .

[57]  M. Fukuda Chapter 8 Leukosialin and the Wiskott-Aldrich syndrome , 1996 .

[58]  M. Mattei,et al.  Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1,6-N-acetylglucosaminyltransferase gene family. , 1993, Genes & development.

[59]  B. Dupont,et al.  Lymphocytotoxic antibodies to non-HLA antigens in the sera of patients with acquired immunodeficiency syndrome (AIDS). , 1983, Progress in clinical and biological research.